高级搜索

食管胃交界部腺癌中MGMT基因启动子区甲基化状态对预后的影响

李宝重, 王文豪, 何明, 陈新, 朱辉, 徐新建, 李飞, 张玉芬

李宝重, 王文豪, 何明, 陈新, 朱辉, 徐新建, 李飞, 张玉芬. 食管胃交界部腺癌中MGMT基因启动子区甲基化状态对预后的影响[J]. 肿瘤防治研究, 2017, 44(4): 257-261. DOI: 10.3971/j.issn.1000-8578.2017.04.004
引用本文: 李宝重, 王文豪, 何明, 陈新, 朱辉, 徐新建, 李飞, 张玉芬. 食管胃交界部腺癌中MGMT基因启动子区甲基化状态对预后的影响[J]. 肿瘤防治研究, 2017, 44(4): 257-261. DOI: 10.3971/j.issn.1000-8578.2017.04.004
LI Baochong, WANG Wenhao, HE Ming, CHEN Xin, ZHU Hui, XU Xinjian, LI Fei, ZHANG Yufen. Methylation Status of MGMT Gene Promoter in Patients with Adenocarcinoma of Esophagogastric Junction and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2017, 44(4): 257-261. DOI: 10.3971/j.issn.1000-8578.2017.04.004
Citation: LI Baochong, WANG Wenhao, HE Ming, CHEN Xin, ZHU Hui, XU Xinjian, LI Fei, ZHANG Yufen. Methylation Status of MGMT Gene Promoter in Patients with Adenocarcinoma of Esophagogastric Junction and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2017, 44(4): 257-261. DOI: 10.3971/j.issn.1000-8578.2017.04.004

食管胃交界部腺癌中MGMT基因启动子区甲基化状态对预后的影响

详细信息
    作者简介:

    李宝重(1974-),男,博士,副主任医师,主要从事胸外科疾病的临床与基础研究

    通讯作者:

    何明,E-mail: heming6699@sina.com

    陈新,E-mail: chenxin6699@sina.com

  • 中图分类号: R735.2

Methylation Status of MGMT Gene Promoter in Patients with Adenocarcinoma of Esophagogastric Junction and Its Relationship with Prognosis

More Information
  • 摘要:
    目的 

    检测食管胃交界部腺癌组织中O6-甲基鸟嘌呤-DNA甲基转移酶(O6-methylguanine-DNA methyltransferase, MGMT)基因启动子区甲基化状态以及蛋白表达情况,评价其与临床参数及预后的关系。

    方法 

    选取107例食管胃交界部腺癌患者,应用甲基化特异性聚合酶链反应(methylmion specific PCR, MSP)检测MGMT基因甲基化情况,免疫组织化学法检测MGMT蛋白表达情况,分析两者与临床特征及生存时间的关系。

    结果 

    癌组织中MGMT基因启动子区甲基化率显著高于癌旁正常组织;癌组织中MGMT蛋白阳性率显著低于癌旁正常组织。Spearman等级相关分析表明MGMT基因启动子区甲基化与MGMT蛋白表达呈负相关。MGMT基因启动子甲基化及蛋白表达与淋巴结转移、pTNM分期之间具有相关性。多因素Cox回归分析,MGMT基因启动子区甲基化、MGMT蛋白表达及pTNM分期是影响患者生存的独立预后因素。

    结论 

    MGMT基因启动子甲基化、MGMT蛋白表达与pTNM分期是影响食管胃交界部腺癌患者预后的独立影响因素。

     

    Abstract:
    Objective 

    To detect the methylation status of O6-methylguanine-DNA methyltransferase (MGMT) promoter and its protein expression in adenocarcinoma of esophagogastric junction (AEJ) tissues. The relationship of MGMT methylation status and its protein expression with clinical features and survival were also analyzed.

    Methods 

    The methylation status of MGMT promoter was detected by methylation specific polymerase chain reaction (MSP) in 107 AEJ cases. Immunohistochemistry staining was used to detect protein expression in the same group of specimen. Then, the relationship of MGMT methylation with clinical features and prognosis were analyzed.

    Results 

    The promoter methylation rate of MGMT in cancerous specimen was higher than that in adjacent normal group. However, the MGMT expression rate was opposite. A correlation between promoter methylation of MGMT and protein expression were established by Spearman correlation analysis. MGMT promoter methylation and its protein expression had significant correlation with lymph node metastasis and pTNM stage. The Cox multivariate regression analysis indicated that MGMT promoter methylation, MGMT protein expression and pTNM stage were significant risk factors.

    Conclusion 

    The promoter methylation of MGMT, MGMT protein expression and pTNM stage might be significant influence factors for 5 years survival time of AEJ patients.

     

  • 图  1   食管胃交界部腺癌组织中MGMT启动子甲基化

    Figure  1   Methylation status of MGMT promoter in adenocarcinoma of esophagogastric junction

    图  2   食管胃交界部腺癌组织中MGMT蛋白表达 (SP×400)

    Figure  2   The expression of MGMT protein in adenocar cinoma of esophagogastric junction tissues (SP×400)

    表  1   MGMT基因启动子区甲基化和MGMT蛋白表达与临床特征的相关性

    Table  1   Relationship of MGMT methylation and its expression with clinical features

    下载: 导出CSV

    表  2   MGMT引物序列、产物大小及退火温度

    Table  2   Primer sequence, product size and annealing temperature of MGMT

    下载: 导出CSV

    表  3   MGMT基因启动子区甲基化状态与MGMT蛋白表达的相关性 (n)

    Table  3   Correlation between promoter methylation of MGMT and MGMT protein expression (n)

    下载: 导出CSV

    表  4   影响食管胃交界部腺癌术后患者预后的相关分析

    Table  4   Prognosis-related factors in patients with adenocarcinoma of esophagogastric junction

    下载: 导出CSV
  • [1]

    Shapiro J, van Lanschot JJ, Hulshof MC, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial[J]. Lancet Oncol, 2015, 16(9): 1090-8. doi: 10.1016/S1470-2045(15)00040-6

    [2]

    Mokhtar M, Kondo K, Namura T, et al. Methylation and expression profiles of MGMT gene in thymic epithelial tumors[J]. Lung Cancer, 2014, 83(2): 279-87. doi: 10.1016/j.lungcan.2013.12.004

    [3]

    Banzai C, Nishino K, Quan J, et al. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma[J]. Inter J Clin Oncol, 2013, 19(1): 127-32. doi: 10.1007/s10147-013-0530-0

    [4] 孟庆山, 王建军, 李振芬, 等.食管癌中DNA修复基因MGMT启动子区CpG岛过甲基化研究[J].肿瘤, 2006, 26(8): 761-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ABJB200902010.htm

    Meng QS, Wang JJ, Li ZF, et al. Hypermethylation of CpG island in promoter region of DNA repair gene MGMT in esophageal carcinoma[J]. Zhong Liu, 2006, 26(8): 761-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ABJB200902010.htm

    [5]

    Kreth S, Thon N, Eigenbrod S, et al. O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation[J]. PLoS One, 2011, 6(2): e17156. doi: 10.1371/journal.pone.0017156

    [6]

    Ogino S, Hazra A, Tranah GJ, et al. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer[J]. Carcinogenesis, 2007, 28(9) : 1985-90. doi: 10.1093/carcin/bgm160

    [7]

    Geutjes EJ, Bajpe PK, Bernards R, et al. Targeting the epigenome for treatment of cancer[J]. Oncogene, 2012, 31(34): 3827-44. doi: 10.1038/onc.2011.552

    [8]

    Chen C, Yin B, Wei Q, et al. Aberrant DNA methylation in thymic epithelial tumors[J]. Cancer Invest, 2009, 27: 582-91. doi: 10.1080/07357900802620869

    [9] 郭晓波, 于颖彦.胃癌相关基因启动子甲基化的研究进展[J].诊断学理论与实践, 2009, 8(1): 93-6. http://cdmd.cnki.com.cn/Article/CDMD-10392-2006170216.htm

    Guo XD, Yu YY. Advances in the study of promoter methylation in gastric cancer related gene[J]. Zhen Duan Xue Li Lun Yu Shi Jian, 2009, 8(1): 93-6. http://cdmd.cnki.com.cn/Article/CDMD-10392-2006170216.htm

    [10] 朱凌冬, 蔡景龙, 远里美. O6-甲基鸟嘌呤-DNA-甲基转移酶的研究进展[J].肿瘤防治研究, 2005, 32(12): 802-4. doi: 10.3971/j.issn.1000-8578.2218

    Zhu LD, Cai JL, Yuan LM. Progress on O6-methylguanine-DNA methyltransferase[J]. Zhong Liu Fang Zhi Yan Jiu, 2005, 32(12): 802-4. doi: 10.3971/j.issn.1000-8578.2218

    [11]

    Esteller M. Epigenetics in cancer[J]. N Engl J Med, 2008, 358(11): 1148-59. doi: 10.1056/NEJMra072067

    [12]

    Kitajima Y, Miyazaki K, Matsukura S, et al. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer[J]. Gastric Cancer, 2003, 6(2): 86-95. doi: 10.1007/s10120-003-0213-z

    [13]

    Yousuf A, Bhat MY, Pandith AA, et al. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area[J]. Cell Oncol (Dordr), 2014, 37(4): 245-52. doi: 10.1007/s13402-014-0179-3

    [14] 陈祥锦, 张惠灏, 郑炜, 等.肝细胞癌p16基因甲基化及其对mRNA表达的影响[J].中国癌症杂志, 2005, 15(6): 569-71. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ200506020.htm

    Chen XR, Zhang HH, Zheng W, et al. p16 gene methylation status of and its effect on mRNA expression in hepatocellular carcinoma[J]. Zhongguo Ai Zheng Za Zhi, 2005, 15(6): 569-71. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ200506020.htm

图(2)  /  表(4)
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-04-10
  • 修回日期:  2016-10-18
  • 网络出版日期:  2024-01-12
  • 刊出日期:  2017-04-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭